Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Related press release
SIOX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-8 No. 333-206300) pertaining to the 2015 Equity Incentive Plan,
(2) Registration Statement (Form S-8 No. 333-215386) pertaining to the 2015 Equity Incentive Plan, and
(3) Registration Statement (Form S-3 No. 333-215387) of Axovant Sciences Ltd.;
of our report dated June 13, 2017, with respect to the consolidated financial statements of Axovant Sciences Ltd. included in this Annual Report (Form 10-K) of Axovant Sciences Ltd. for the year ended March 31, 2017.
/s/ Ernst & Young LLP
Iselin, NJ
June 13, 2017
1